Leadership Overview
Torrent Pharma has 7 executives leading key functions including strategy, planning, operations, finance, quality assurance, and management.
Focused on delivering high-quality therapeutic solutions, Torrent Pharma advances global health through scientific excellence and a commitment to developing affordable medicines across diverse medical segments.
Focused on delivering high-quality therapeutic solutions, Torrent Pharma advances global health through scientific excellence and a commitment to developing affordable medicines across diverse medical segments.
Leadership Roles at Torrent Pharma
Sandeep Gemini - Chief Executive Officer
Sandeep Gemini, the Chief Executive Officer at Torrent Pharma, directs the overarching corporate strategy and long-term vision for the organization. By prioritizing research and development, the Chief Executive Officer ensures the company maintains a competitive edge in cardiovascular and central nervous system therapeutic markets. Sandeep Gemini oversees the integration of advanced infrastructure to support the production of high-quality, affordable medicines for patients worldwide. This leadership role involves constant collaboration with the Board to align operational goals with the broader mission of the Torrent Group. Through rigorous oversight of scientific initiatives, the Chief Executive Officer drives innovation across all international markets. By fostering a culture of excellence, the Chief Executive Officer secures the company's position as a leader in the pharmaceutical industry. Ultimately, the Chief Executive Officer maintains the financial and operational health of the enterprise while expanding the global footprint of the organization.
Anantshree Sharma - Chief Executive Officer, Strategic Planning 's Office
Anantshree Sharma, the Chief Executive Officer, Strategic Planning 's Office at Torrent Pharma, architects the long-term growth roadmap and market expansion strategies. By analyzing global pharmaceutical trends, the Chief Executive Officer, Strategic Planning 's Office identifies key opportunities in gastro-intestinal care and cosmo-dermatology. Anantshree Sharma coordinates with cross-functional teams to ensure that strategic objectives translate into actionable business outcomes. This role involves evaluating potential partnerships and acquisitions to strengthen the company's international presence. By optimizing resource allocation, the Chief Executive Officer, Strategic Planning 's Office supports the development of new therapeutic pipelines. The Chief Executive Officer, Strategic Planning 's Office monitors market shifts to maintain the company's agility in a complex regulatory environment. Through data-driven decision-making, the Chief Executive Officer, Strategic Planning 's Office ensures that the organization remains at the forefront of medical innovation while delivering consistent value to stakeholders across all operational regions.
Shweta Sabbani - Chief Executive Officer, Strategic Planning Office (India)
Shweta Sabbani, the Chief Executive Officer, Strategic Planning Office (India) at Torrent Pharma, drives the domestic market strategy and regional operational efficiency. By focusing on the specific needs of the Indian healthcare sector, the Chief Executive Officer, Strategic Planning Office (India) manages the expansion of product portfolios in diabetology and pain management. Shweta Sabbani oversees the alignment of local manufacturing capabilities with national demand to ensure consistent supply chain performance. This leadership role involves navigating the unique regulatory landscape of the Indian market while maintaining high standards of scientific integrity. By implementing localized marketing and distribution strategies, the Chief Executive Officer, Strategic Planning Office (India) maximizes market penetration. The Chief Executive Officer, Strategic Planning Office (India) collaborates with internal stakeholders to refine operational processes and improve patient access to essential treatments. Through strategic foresight, the Chief Executive Officer, Strategic Planning Office (India) strengthens the company's foundational role within the domestic pharmaceutical landscape.
Sudhir Menon - Executive Director & Chief Financial Officer
Sudhir Menon, the Executive Director & Chief Financial Officer at Torrent Pharma, directs the financial strategy, capital allocation, and fiscal reporting for the organization. By managing the company's investment in research and development, the Executive Director & Chief Financial Officer ensures that financial resources support the long-term innovation goals of the business. Sudhir Menon oversees the financial health of international operations, ensuring compliance with global accounting standards and regulatory requirements. This leadership role involves providing the Board with critical insights into market performance and revenue growth across various therapeutic segments. By optimizing the capital structure, the Executive Director & Chief Financial Officer mitigates financial risks and enhances shareholder value. The Executive Director & Chief Financial Officer collaborates with other C-suite leaders to align budgetary priorities with the company's strategic mission. Through disciplined financial oversight, the Executive Director & Chief Financial Officer secures the necessary funding for future expansion and infrastructure development.
Hasmukh Patel - Chief Operating Officer
Hasmukh Patel, the Chief Operating Officer at Torrent Pharma, manages the daily execution of manufacturing processes and supply chain logistics. By overseeing the advanced infrastructure required for pharmaceutical production, the Chief Operating Officer ensures that all facilities operate at peak efficiency. Hasmukh Patel coordinates the efforts of the scientific workforce to maintain high-quality standards across all therapeutic categories, including anti-infectives and gynaecology. This role involves streamlining production workflows to reduce costs and improve delivery timelines for global markets. By implementing lean manufacturing principles, the Chief Operating Officer supports the company's commitment to providing affordable medicines. The Chief Operating Officer monitors operational metrics to identify areas for continuous improvement and technological integration. Through effective management of internal resources, the Chief Operating Officer ensures that the organization meets its production targets while adhering to strict safety and quality protocols. Ultimately, the Chief Operating Officer maintains the operational backbone of the company.
Vidyasagar Gotpagar - Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations )
Vidyasagar Gotpagar, the Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) at Torrent Pharma, enforces rigorous quality standards across all contract manufacturing sites. By monitoring production locations, the Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) ensures that every product meets the company's high benchmarks for safety and efficacy. Vidyasagar Gotpagar oversees the audit processes for external partners to maintain consistency in the supply chain. This role involves integrating quality control measures into the procurement-to-pay cycle to safeguard the integrity of the pharmaceutical portfolio. By analyzing quality data, the Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) identifies potential risks and implements corrective actions. The Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) collaborates with the marketing and operations teams to ensure that quality remains a core component of the brand promise. Through constant vigilance, the Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) protects the company's reputation.
Akash Vimal - Senior Executive Manager
Akash Vimal, the Senior Executive Manager at Torrent Pharma, coordinates departmental initiatives and supports the execution of key business projects. By facilitating communication between different functional units, the Senior Executive Manager ensures that organizational goals remain synchronized across the company. Akash Vimal oversees the implementation of internal processes that improve productivity and cross-departmental collaboration. This role involves managing project timelines and resource allocation to support the development of new therapeutic solutions. By providing administrative and operational support to senior leadership, the Senior Executive Manager helps streamline decision-making processes. The Senior Executive Manager monitors project performance metrics to ensure that all initiatives align with the company's mission of scientific excellence. Through effective coordination, the Senior Executive Manager assists in the successful delivery of strategic objectives. By maintaining a focus on operational efficiency, the Senior Executive Manager contributes to the overall growth and stability of the organization in a competitive pharmaceutical market.
Explore Leadership Teams in Manufacturing
Founded in 1781, Takeda Pharmaceutical Company engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company is headquartered in Tokyo, Japan
Company Leadership JT
GL
RF
NS
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.
Company Leadership CD
NB
ES
SS
Founded in 1958 and headquartered in Chatswood, Australia, iNova Pharmaceuticals is an international organization that develops, markets, and sells a wide-range of prescription medicines and non-prescription consumer health products across Asia, Australia and New Zealand, and Africa.
Company Leadership DS
JR
SE

Lantheus is a healthcare technology company headquartered in Bedford, Massachusetts with additional offices in New Jersey, Canada, and Sweden. Founded in 1956, the company pioneers medical imaging technologies and provides innovative diagnostics, targeted therapeutics, and artificial intelligence solutions for healthcare. Lantheus specializes in developing software and health technologies that empower clinicians to effectively identify, treat, and monitor various diseases. The company maintains a diverse product portfolio focused on enhancing patient care through advanced medical imaging and diagnostic tools. As a publicly traded company since 2019, Lantheus continues to expand its global presence while maintaining its commitment to innovation in healthcare technology.
Company Leadership


